Catalyst
Slingshot members are tracking this event:
Top-line Data from Phase 2 Proof-of-Concept Trial of SAGE-217 in Parkinson's Disease
Do you think this event is important to the companies below? How will it affect their stock price?
| Related Companies | Importance
|
Impact on Stocks
|
||||
|---|---|---|---|---|---|---|
| SAGE |
|
|
||||
Slingshot Insights Explained
Catalyst Date
Occurred on:
Feb 13, 2017
Occurred Source:
http://www.businesswire.com/news/home/20170213005345/en/
Related Projects
-
Don’t see a project related to the catalyst you care about?
Related Keywords
Proof-of-concept, Sage-217, Parkinson's Disease
